Official Title
Evaluation of the Relationship Between Non-attendance to Appointments and Adherence to Medical Indications, in Adult Patients, With Type 2 Diabetes Mellitus, During the COVID-19 Pandemic: Cross-sectional Studio.
Brief Summary

We will conduct a cross-sectional study involving adults with type 2 diabetes mellitus.Our primary objective is to evaluate the association between nonattendance andparticipants' adherence to both pharmacological and non-pharmacological medicalrecommendations, as well as COVID-19 prevention measures. Additionally, we will assessthe adherence rates to these medical recommendations, COVID-19 prevention protocols, andthe recommended health care practices and controls for patients with type 2 diabetesmellitus.

Detailed Description

Non-attendance at outpatient visits and lack of adherence to medical recommendations are
prevalent issues that negatively impact the health care system. While tools exist to
assess pharmacological adherence, evaluating adherence to non-pharmacological
recommendations remains challenging. Some studies suggest using nonattendance as an
objective and easily measurable marker of adherence.

The aim of this study is to evaluate the association between nonattendance and adherence
to medical recommendations in adults with type 2 diabetes mellitus.

We will conduct a cross-sectional study involving adults with type 2 diabetes mellitus.
We will evaluate the association between participants' nonattendance and their adherence
to both pharmacological and non-pharmacological medical recommendations, as well as
COVID-19 prevention measures. Additionally, we will assess the adherence rates to these
recommendations, COVID-19 prevention measures, and the recommended health care practices
and controls for patients with type 2 diabetes mellitus.

Completed
No-Show Patients
Therapeutic Adherence and Compliance
Type 2 Diabetes Mellitus
COVID-19
Eligibility Criteria

Inclusion Criteria:

- Adult patients (over 18 years old), affiliated with the medical insurance of the
Hospital Italiano de Buenos Aires for at least two years.

- Patients with a diagnosis of type 2 diabetes mellitus at least 2 years before the
date of entry to the study Will be included.

Exclusion Criteria:

- Refusal to participate or to the informed consent process.

- Difficulties with language or comprehension (includes pathologies that alter the
understanding of the indications or compliance with them (dementia, encephalopathy,
intellectual disability, psychiatric disorders).

- Recent hospitalization (the month before the phone call).

- Medical follow-up outside of Hospital Italiano de Buenos Aires.

- Work as health personnel.

- Communication failure (wrong phone number or no response to 3 calls on different
days and times)

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Argentina
Locations

Hospital Italiano de Buenos Aires
Ciudad Autónoma de Buenos Aire, Buenos Aires F.D. 3433955, Argentina

Javier Nicolás Giunta, MD, Study Director
Hospital Italiano de Buenos Aires

Hospital Italiano de Buenos Aires
NCT Number
Keywords
No Show Patients
Patient Compliance
Type 2 diabetes mellitus
Covid-19
MeSH Terms
No-Show Patients
Treatment Adherence and Compliance
Diabetes Mellitus, Type 2
COVID-19
Patient Compliance